Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
advances in neurology
adverse drug reaction
akathisia
albumin
alcohol
alcoholism
alpha-synuclein
alternative medicine
Alzheimer's disease
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, prognosis
amyotrophic lateral sclerosis, treatment of
aneurysm
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
angiotensin II receptor blocker
antibiotics
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antihypertensive
antioxidant
apolipoprotein E
apoptosis
aptiganel
arm weakness
ascorbic acid
aspirin
atherosclerosis, generalized
autonomic dysfunction
axonal degeneration
biologic markers
BiPAP
blacks
blood pressure
body temperature
brain atrophy
brain transplantation
bulbar palsy
bulbar palsy, progressive
burning paresthesia
caffeine
calcium antagonist
calcium antagonist, side effects of
cardiac arrest
cardiac arrest and resuscitation
caspases
CAT scan
CAT scan, abnormal
CAT scan, disappearing lesion on
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, xenon-enhanced
cerebral blood flow
cerebral edema
cerebral embolism
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, neonatal
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cholesterol
cholesterol, LDL
cigarette smoking
citicoline
clinical trials
cognition
coma
controversies in neurology
cooling therapy
coronary artery disease
craniectomy, decompressive
crying, pathologic
DATATOP study
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, incidence
dementia, prevention of
dementia, treatment of
deprenyl
diabetes mellitus
diet
dimebon
disability, neurological
distal muscle weakness
dopamine agonist
dopamine receptor, D2
drug induced neurologic disorders
dying
dysarthria
dyskinesia, buccal lingual facial
dysphagia
efficacy
embolism
emergencies, neurologic
emergency medical technicians
emotional lability
encephalopathy, post traumatic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endovascular therapy
enzyme inhibition
epidemiology of neurology
excitotoxin
fasciculation
fatigue
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibroblast growth factor
fish
flavonoids
foot drop
free radical
fruits
fumarate
gadolinium
gender
Glasgow coma score
glutamic acid
head injury
head injury, evaluation of
head injury, management of
head injury, pathophysiology of
head injury, prevention
head injury, prognosis in
headache
headache, treatment of
hemodilution
hemorrhage, intracranial, newborn
hemorrhage, periventricular
heparin
heralding manifestation
herpes simplex encephalitis, diagnosis of
histamine-2 receptor blockers
HMGcoA reductase inhibitors
hormone replacement
hospice
hydrocephalus
hyperreflexia
hypertension
hyperthermia
hyperuricemia
hypotension, systemic
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
ibuprofen
immunomodulation
indomethacin
intellectual deficit
intracranial pressure monitoring
intraventricular hemorrhage
intrinsic hand muscles, wasting of
ischemic penumbra
Kleine-Levin syndrome
lacunar infarction
laughing, pathologic
L-dopa
leg weakness, unilateral
Lewy body
Lewy body disease, diffuse
life expectancy
lipid lowering agent
lithium
low birth weight
lubeluzole
magnesium sulfate
melatonin
mental status, evaluation of
middle cerebral artery, occlusion of
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
minocycline
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRS
multiple sclerosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle wasting, diffuse
N-acetyl-L-aspartic acid
nerve growth factor
neuroendocrinology
neurologic disease
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination
neurologic symptoms
neurologic testing
neuronal cell death
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotransmitter
nicardipine
nimodipine
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
old age, neurology of
pallidotomy
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
pathology
pineal
piracetam
platelet inhibiting drugs
practice guidelines
pravastatin
preclinical
premarin
prevention of neurologic disorders
prognosis
psychological testing
rasagiline
rehabilitation for neurologic disorders
research
respirator
respiratory failure
review article
riluzole
risk factors
risk-benefit assessment
safety
seizure
seizure, treatment of
simvastatin
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
sodium-glucoe cotransporter-2 inhibitors
statin therapy
stimulant drugs
streptokinase
stroke unit
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
tea
tetracycline
thrombolysis, mechanical
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor, thalamic stimulation for suppression of
tripping
vasospasm, cerebral
vegetables
vestibular function, tests of
vitamin A
vitamin D
vitamin E
vitamin supplementation
whites
wine
Showing articles 1300 to 1350 of 3460 << Previous Next >>

Spectrum and Prognosis of Neurologic Complications After Hematopoietic Transplantation
Neurol 67:1990-1997, Denier,C.,et al, 2006

Psychotropic Effects of Antiepileptic Drugs
Neurol 67:1916-1925, Ettinger,A.B., 2006

Seizures During Stroke Thrombolysis Heralding Dramatic Neurologic Recovery
Neurol 67:2048-2049, Rodan,L.H.,et al, 2006

Primary Lymphoma of CNS, Mycophenolate Mofetil and Lupus
Lupus 15:886-888, Finelli,P.F.,et al, 2006

Charcot Neuroarthropathy in the Era of HAART
Lancet 367:274, Oh-Park,M.,et al, 2006

Extrathymic Tumors in Patients With Myasthenia Gravis, A 35-Year Retrospective Study
The Neurologist 12:53-55, Wakata,N.,et al, 2006

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006

Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006

Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke 37:419-424, Choi,J.H.,et al, 2006

Cliniclopath Conf., Granulomatous Amebic Encephalitis Due to Acanthamoeba
NEJM 355:2678-2689, Case 39-2006, 2006

Developmental Neurotoxivity of Industrial Chemicals
Lancet 368:2167-2178, Grandjean,P. &Landrigan,P.J., 2006

Intravascular Lymphoma: The Oncologists "Great Imitator"
The Oncologist 11:496-502, Zuckerman, D.,et al, 2006

Cyanide Intoxication with Encephalitis Clinic: A Case Report
East J Med 11:22-25, Dogan, M.,et al, 2006

Diffusion-Weighted Cranial MR Imaging Findings in a Patient with Hemophagocytic Syndrome
AJNR 27:1312-1314, Ozgen, B.,et al, 2006

Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
J Clin Oncol 24:1904-1909, Low, W.K.,et al, 2006

Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005

Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005

Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005

Central Nervous System Lymphoma Associated with Mycophenolate Mofetil in Lupus Nephritis
Lupus 14:910-913, Dasgupta,N.,et al, 2005

Capecitabine-Induced Multifocal Leukoencephalopathy: A Report of Five Cases
Neurol 65:1792-1794, Videnovic,A.,et al, 2005

Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

Statins and Cognitive Functioning the Elderly
Neurol 65:1388-1394, Bernick,C.,et al, 2005

Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Stroke 36:e2490-e2492, Mandava,P. &Kent,T.A., 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Reversible Anorgasmia With Topiramate Therapy for Migraine
Neurol 65:1333-1334, Newman,L.C.,et al, 2005

Evaluation of Combination Therapy Using Aciclovir and Corticosteroid in Adult Patients with Herpes Simplex Virus Encephalitis
JNNP 76:1544-1549,1469, Kamei,S.,et al, 2005

Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005

Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005

Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

Primary CNS Lymphoma in Myasthenic on Long-term Azathioprine
J NeuroOncol 74:91-92, Finelli,P.F., 2005

Primary CNS Lymphoma Complicating Treatment of Myasthenia Gravis with Mycophenolate Mofetil
Neurol 65:639-641, Vernino,S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Acute Painful Neuropathy in Thallium Poisoning
Neurol 65:302-304, Kuo,H.-C.,et al, 2005

Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

Diffusion-Weighted Imaging of Radiation-Induced Brain Injury for Differentiation from Tumor Recurrence
AJNR 26:1455-1460,1305, Asao,C.,et al, 2005

Blinded Pressure and Pain
Lancet 365:2244, Rahim,S.A.,et al, 2005

Bells Palsy
BMJ 330:1374, Piercy, J, 2005



Showing articles 1300 to 1350 of 3460 << Previous Next >>